Auston Cherbonneaux: Why Erythritol Just Joined the High-Hazard List
Auston Cherbonneaux, Science Communicator, Author, Publisher, shared a post on LinkedIn about an article by Marco Witkowski, published in Nature Medicine, adding:
“Ingredient Alert
Erythritol (common non caloric sweetener) has evidence to suggest it compromises the blood-brain barrier over time.
This one is a bit more complicated. Still, enough evidence to start taking extreme caution for populations vulnerable to stroke, cardiac events, and thrombosis.
First, a study of about 1000 people suggests that people who are in the upper quartile of erythritol in blood were twice as likely to suffer a major cardiac event compared to the first quartile.
The conclusion to the study referenced in the article [Abstract]:
‘Our findings reveal that erythritol is both associated with incident MACE risk and fosters enhanced thrombosis. Studies assessing the long-term safety of erythritol are warranted.’
Second, experimental finding to this point is only on cells in a petri dish, next step is “blood vessels on a chip” to better mimic physiology.
I don’t need a third.
This is going on the ‘habitual extreme hazard‘ list.”
Title: The artificial sweetener erythritol and cardiovascular event risk
Authors: Marco Witkowski, Ina Nemet, Hassan Alamri, Jennifer Wilcox, Nilaksh Gupta, Nisreen Nimer, Arash Haghikia, Xinmin S. Li, Yuping Wu, Prasenjit rasad Saha, Ilja Demuth, Maximilian König, Elisabeth Steinhagen-Thiessen, Tomas Cajka, Oliver Fiehn, Ulf Landmesser, W. H. Wilson Tang, Stanley L. Hazen

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support
-
Nov 17, 2026, 23:34Ahmed Bennis: Is Aspirin Therapy Enough for VTE Prevention After Arthroplasty?
-
Nov 17, 2026, 23:33Remi Remakanth: The Role of Transfusion Medicine in HLA Antibody Testing and Transplant Desensitization